Hideki Saitsu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Hideki Saitsu has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Ken Kawabe
Department of Gastroenterology, National Hospital Organization Kyushu Medical Center, Japan
1 shared publication - Masatoshi Murakami
Department of Gastroenterology, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan
1 shared publication - Masayuki Hijioka
Department of Gastroenterology, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan
1 shared publication - Munehiro Yoshitomi
Department of Hepato-Biliary-Pancreatic Surgery, Clinical Research Institute, National Hospital Organization Kyushu Medical Center, 1-8-1 Jigyohama Chuo-ku, Fukuoka, 810-8563, Japan
1 shared publication - Seiya Momosaki
Department of Pathology, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan
1 shared publication - Shin Sasaki
Department of Hepato-Biliary-Pancreatic Surgery, Clinical Research Institute, National Hospital Organization Kyushu Medical Center, 1-8-1 Jigyohama Chuo-ku, Fukuoka, 810-8563, Japan
1 shared publication
Latest Publications
- Open Access
- 30 July 2019
- Published by Springer Nature in Surgical Case Reports
- Vol. 5 (1) , 1-6
Conversion surgery for initially unresectable carcinoma of the ampulla of Vater following pathological complete response to chemotherapy: a case report
Carcinoma of the ampulla of Vater with distant metastases is regarded as unresectable. Systemic chemotherapy is basically the treatment of choice for such tumors. A 68-year-old woman was referred to our hospital and diagnosed with carcinoma of the ampulla of Vater with lymph node and multiple liver metastases. She underwent systemic chemotherapy with a combination of gemcitabine and cisplatin. After 19 months of treatment, the primary tumor and liver metastases were difficult to detect on follow-up images. Shrinkage of the enlarged lymph nodes was also confirmed. Surgical resection was performed with curative intent after a multidisciplinary meeting. Pathological examination of the resected specimen showed no residual tumors. Systemic chemotherapy achieved a pathological complete response. The postoperative course was uneventful, and the patient remained free of recurrent disease at 10 months of follow-up. This case shows the possibility of conversion surgery after systemic chemotherapy for carcinoma of the ampulla of Vater.
- 30 July 2019
- Published by Springer Nature in Surgical Case Reports
- Vol. 5 (1) , 1-6
Open AccessConversion surgery for initially unresectable carcinoma of the ampulla of Vater following pathological complete response to chemotherapy: a case report
Carcinoma of the ampulla of Vater with distant metastases is regarded as unresectable. Systemic chemotherapy is basically the treatment of choice for such tumors. A 68-year-old woman was referred to our hospital and diagnosed with carcinoma of the ampulla of Vater with lymph node and multiple liver metastases. She underwent systemic chemotherapy with a combination of gemcitabine and cisplatin. After 19 months of treatment, the primary tumor and liver metastases were difficult to detect on follow-up images. Shrinkage of the enlarged lymph nodes was also confirmed. Surgical resection was performed with curative intent after a multidisciplinary meeting. Pathological examination of the resected specimen showed no residual tumors. Systemic chemotherapy achieved a pathological complete response. The postoperative course was uneventful, and the patient remained free of recurrent disease at 10 months of follow-up. This case shows the possibility of conversion surgery after systemic chemotherapy for carcinoma of the ampulla of Vater.